Navigation Links
Marketing and Meeting Details (M2D) Officially Launches an Innovative Life Sciences Marketing and Communications Company
Date:11/19/2007

Clients to Benefit from a Distinctive Union of Pharmaceutical, Biotech and Medical Device Experience in Professional Education, Brand Management and

Special Event Planning

NORTH BRANFORD, Conn., Nov. 19 /PRNewswire/ -- M2D management announces the official launch of a progressive marketing and communications firm that will focus on the life sciences sector. M2D is the brainchild of two individuals with clear records of success in this highly regulated sector, Christine Lawton and Timothy Roe.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071119/NEM104LOGO )

Christine is a respected meetings and events professional with almost two decades of experience working on both the client and agency sides of the business. Her accomplishments span several hundred meetings and conventions of all varieties, both domestically and internationally, during her pharmaceutical tenure.

Timothy is a pharmaceutical and medical device professional with over 15 years of progressively responsible positions in Sales and Marketing. Timothy is known in the industry as having the business acumen to maximize a product's global commercial return and asset value. Timothy has managed the "Big-C" brands, Celebrex(R), Cipro(R) and Clarinex(R) as well as several smaller niche products.

M2D provides tireless proactive thinking that eliminates problems associated with vendor complacency. Timothy Roe adds:

"As a former Product Manager, I recognize what is important to clients. Vendors should always add more detailed and proactive thought to their work, even after the 'honeymoon' period. There continues to be a tremendous need for much higher performance, and smaller firms like M2D are already there. Those who can do it cost-effectively will win."

M2D's uniqueness results from a lifetime of client-side interactions with vendors. Clients receive genuine strategic attention, but the difference lies with M2D's painstakingly detailed approach to tactical execution. The company utilizes the most advanced analytics and metric reporting tools available and offers them either gratis or at attractive pricing.

M2D's core capabilities include:

-- Thorough Understanding of Compliance Laws

-- Lowest Guaranteed Travel Rates

-- Investigator & Sales Meetings

-- Conventions & Symposia; Ad Boards & Round Tables

-- Opinion Leader & Speaker Bureau Management

-- Promotional Peer-to-Peer Events

-- CME-based Programming

-- Surrogate Brand Management and Audits

-- Advanced Webinars & Web Conferences with Real-Time Polling

M2D's website http://www.m2details.com.

Celebrex, Cipro and Clarinex are products of Pfizer, Bayer and Schering- Plough respectively.

Contact: M2D Media Relations

Phone: 781-210-4710

Fax: 781-210-4711

Email: MediaRelations@m2details.com


'/>"/>
SOURCE Marketing and Meeting Details (M2D)
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
2. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
3. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
4. Fitness Champion Natalie Waples to be Spokesperson for Natural Nutrition International Direct Marketing Campaign
5. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
6. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
7. Sterling Life Enhances Marketing Operations Controls to Better Serve Medicare Beneficiaries
8. Former Ronco President Tim Dupler Signs International Direct Sales and Marketing Contract with Natural Nutrition
9. Eastern Alliance Insurance Group Appoints Cox Regional Marketing Director for Southeast
10. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
11. Scientific Publications Strategy & Delivery Shifts from Marketing to Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... Fla. (PRWEB) , ... August 19, 2017 , ... ... Taufiq Ahmed, M.D., has joined its Orlando location as an interventional pain management ... anesthesiology, a focus on the treatment of migraine headaches, and significant experience in ...
(Date:8/18/2017)... ... August 18, 2017 ... ... For Immediate Release                Contact: Julian Teixeira, August 18, 2017                    202-478-8564 / ... Relationship Advice from their Fathers , Contrary to a ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... “Vision & Hearing” campaign, advocating for active, healthy lifestyles and highlighting the importance ... for individuals with hearing impairments and shares the latest innovations in hearing aid ...
(Date:8/18/2017)... ... August 18, 2017 , ... Radabaugh & Associates, ... to communities in North-Central West Virginia, is embarking on a cooperative charity effort ... the area. , The Chestnut Mountain Ranch (CMR) is a Christ-centered boarding school ...
(Date:8/18/2017)... ... August 18, 2017 , ... Goss & ... serves residential and commercial clients in the greater Houston region, is helping locally ... for the fight against cancer. , Founded by Tony and Amber Bender after ...
Breaking Medicine News(10 mins):
(Date:7/31/2017)... , July 31, 2017 7D Surgical, developer ... Medical has purchased the 7D Surgical System to support its ... Washington D.C. and Virginia.  7D Surgical has ... for many of the premier medical facilities within those markets. ... ...
(Date:7/28/2017)... FLINT, Mich. , July 28, 2017 EnvoyHealth, ... (CMT) to pilot a program for CleverCap LITE, a ... CMT strives to deliver innovative health technology solutions ... adherence. CleverCap LITE ... The compact, high-tech bottle cover: ...
(Date:7/27/2017)... Pa., July 27, 2017  West Pharmaceutical Services, Inc. ... results for the second-quarter 2017 and updated financial guidance ... Second-Quarter 2017 Highlights Reported net ... over the prior-year quarter. Net sales at constant currency ... reported-diluted EPS was $0.51, compared to $0.60 in the ...
Breaking Medicine Technology: